PharmaShots Weekly Snapshot (October 21-25, 2019)

1. Urology San Antonio Collaborates with Anixa Biosciences on Ccheck Prostate Cancer Study

Published: Oct 25, 2019 | Tags: Urology San Antonio, Collaborates, Anixa Biosciences, Ccheck, Prostate Cancer Study

2. NHS England Signs an Agreement with Vertex to Access All Licensed Cystic Fibrosis Therapies

Published: Oct 24, 2019 | Tags: NHS England, Signs, Agreement, Vertex, Access, Licensed, Cystic Fibrosis Therapies

3. Zentiva to Acquire Alvogen’s Generics and OTC Business in Central and Eastern Europe

Published: Oct 25, 2019 | Tags: Zentiva, Acquire, Alvogen, Generics, OTC, Business, Central and Eastern Europe

 4. Astellas’ Xospata (gilteritinib) Receives EC’s Approval as Monotherapy for Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 Mutation

Published: Oct 25, 2019 | Tags: Astellas, Xospata, gilteritinib, Receives, EC, Approval, Monotherapy, Relapsed, Refractory, Acute Myeloid Leukemia, FLT3 Mutation

5. Allergan’s BOTOX (onabotulinumtoxinA) Receives the US FDA’s Approval for Pediatric Patients with Lower Limb Spasticity Excluding Spasticity Caused by Cerebral Palsy

Published: Oct 24, 2019 | Tags: Allergan, BOTOX, onabotulinumtoxinA, Receives, US, FDA, Approval, Pediatric Patients, Lower Limb Spasticity, Spasticity Caused by Cerebral Palsy

6. AbbVie Collaborate with Cystic Fibrosis Foundation to Advance CFTR Potentiator

Published: Oct 24, 2019 | Tags: AbbVie, Collaborate, Cystic Fibrosis Foundation, Advance, CFTR Potentiator

7. NovoCodex Collaborates with Ambrx to Develop and Commercialize its ARX305 in China

Published: Oct 23, 2019 | Tags: NovoCodex, Collaborates, Ambrx, Develop, Commercialize, ARX305, China

8. WHO Signs MoU with IGBA for Promoting the Access to Biosimilars and Generics

Published:  Oct 23, 2019 | Tags: WHO, Signs, MoU, IGBA, Promote, Access, Biosimilars, Generics

9. Bausch Health In-Licenses Clearside’s Xipere (triamcinolone acetonide suprachoroidal injectable suspension) For Macular Edema Associated with Uveitis

Published: Oct 24, 2019 | Tags: Bausch Health, In-Licenses, Clearside, Xipere, triamcinolone acetonide suprachoroidal injectable suspension, Macular Edema Associated with Uveitis

10. GSK’s Zejula (niraparib) Receives FDA’s Approval for Late-line Treatment in Women with Recurrent Ovarian Cancer

Published: Oct 23, 2019 | Tags: GSK, Zejula, niraparib, Receives, FDA, Approval, Late-line Treatment, Women, Recurrent Ovarian Cancer

11. Novartis Collaborates with Pliant Therapeutics to Develop Therapies for NASH and Fibrotic Diseases

Published: Oct 24, 2019 | Tags: Novartis, Collaborates, Pliant Therapeutics, Develop, Therapies, NASH, Fibrotic Diseases

12. Biomica Signs an Agreement with Weizmann Institute of Science to Develop a Selective Treatment Against Antibiotic-Resistant Bacteria

Published: Oct 23, 2019 | Tags: Biomica, Signs, Agreement, Weizmann Institute of Science, Develop, Selective, Treatment, Against, Antibiotic Resistant Bacteria

13. Brii Biosciences Collaborates with Qpex to Develop and Commercialize Antibiotics for Drug-Resistant Infections in China

Published: Oct 22, 2019 | Tags: Brii Biosciences, Collaborates, Qpex, Develop, Commercialize, Antibiotics, Drug-Resistant Infections, China

14. BerGenBio’s Bemcentinib Receives the US FDA’s Fast Track Designation for Relapsed Acute Myeloid Leukemia

Published: Oct 22, 2019 | Tags: BerGenBio, Bemcentinib, Receives, US, FDA, Fast Track Designation, Relapsed Acute Myeloid Leukemia

15. Biogen and Eisai Plan to File BLA to the US FDA for Aducanumab to Treat Alzheimer’s Disease

Published: Oct 22, 2019 | Tags: Biogen, Eisai, Plan, File, BLA, US, FDA, Aducanumab, Treat, Alzheimer’s Disease

16. Novo Nordisk’s Fiasp (insulin aspart injection) Receives the FDA’s Approval for use in Insulin Infusion Pumps to Treat Type 1 or Type 2 Diabetes

Published: Oct 22, 2019 | Tags: Novo Nordisk, Fiasp, insulin aspart injection, Insulin Infusion Pumps, Type 1 Diabetes, Type 2 Diabetes

17. Alvogen Signs an Exclusive Commercialization Agreement with Three Pharma Companies for PF708 (biosimilar, teriparatide)

Published: Oct 21, 2019 | Tags: Alvogen, Signs, Exclusive, Commercialization Agreement, Three, Pharma Companies, PF708, biosimilar, teriparatide

18. BMS Reports Result of Opdivo (nivolumab) + Yervoy (ipilimumab) + CT in P-III CheckMate-9LA Study as 1L Therapy for Lung Cancer

Published: Oct 22, 2019 | Tags: BMS, Reports, Result, Opdivo, nivolumab, Yervoy, ipilimumab, CT, P-III, CheckMate-9LA, 1L, Lung Cancer

19. Vertex’s Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) Receives the US FDA’s Approval to Treat the Underlying Cause of Cystic Fibrosis

Published: Oct 21, 2019 | Tags: Vertex, Trikafta, elexacaftor, tezacaftor, ivacaftor, Receives, US, FDA, Approval, Treat, Cystic Fibrosis

20. Pfizer and OPKO Reports Results of Somatrogon in P-III Study for Children with Growth Hormone Deficiency

Published: Oct 21, 2019 | Tags: Pfizer, OPKO, Reports, Results, Somatrogon, P-III, Study, Children, Growth Hormone Deficiency

21. Takeda Acquires Exclusive Worldwide License Rights for COUR’s CNP-101 to Treat Celiac Disease

Published: Oct 22, 2019 | Tags: Takeda, Acquires, Exclusive, Worldwide, License, COUR, CNP-101, Celiac Disease

22. Bayer to Terminate its JV Agreement with CRISPR Therapeutics

Published: Oct 21, 2019 | Tags: CRISPR, Casebia Therapeutics, Terminating, JV agreement, Bayer

23. Humana and Microsoft Collaborate to Reimagine Health Leveraging Azure Cloud and AI with Voice Technologies

Published: Oct 21, 2019 | Tags:  Humana, Microsoft, Collaborate, Reimagine, Health, Leveraging, Azure Cloud, AI, Voice Technologies

24. Janssen’s Stelara (ustekinumab) Receives the US FDA’s Approval for Moderately to Severely Active Ulcerative Colitis

Published: Oct 21, 2019 | Tags: Janssen, Stelara, ustekinumab, Receives, US, FDA, Approval, Moderately to Severely Active Ulcerative Colitis

25. Sartorius to Acquire Danaher’s Life Science Portfolio for $750M

Published: Oct 21, 2019 | Tags: Sartorius, Acquire, Danaher, Life Science Portfolio, $750M

26. AstraZeneca’s Farxiga (dapagliflozin) Receives the US FDA’s Approval for Reducing the Risk of Hospitalization for Heart Failure in Patients with Type-2 Diabetes

Published: Oct 21, 2019 | Tags: AstraZeneca, Farxiga, dapagliflozin, Receives, US, FDA, Approval, Reducing, Risk of Hospitalization, Heart Failure, Patients, Type-2 Diabetes

27. GSK to Divest its Rabipur and Encepur Vaccines to Bavarian Nordic for ~1B

Published: Oct 21, 2019 | Tags: GSK, Divest, Rabipur, Encepur, Vaccines, Bavarian Nordic, ~1B

28. Roche Reports Result of Tecentriq (atezolizumab) + Avastin (bevacizumab) in P-III IMbrave150 Study for Unresectable Hepatocellular Carcinoma

Published: Oct 21, 2019 | Tags: Roche, Reports, Result, Tecentriq, atezolizumab, Avastin, bevacizumab, P-III, IMbrave150, Study, Unresectable Hepatocellular Carcinoma